it's the first successful medical treatment of a human fetus for the underlying cause of a genetic disorder, experts say
.
.
march 2009 (23)
.
in a news release, the drug's manufacturer, amgen, said the list price will be 5 a month or ,900 annually. costs to patients may vary depending on insurance.
.
media won�t investigate medically-caused death numbers
.
.